PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer

Uterine serous carcinoma (USC), an aggressive variant of endometrial cancer representing approximately 10% of endometrial cancer diagnoses, accounts for ∼39% of endometrial cancer-related deaths. We examined the role of genomic alterations in advanced-stage USC associated with outcome using paired p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Wendell, Tait, David, Livasy, Chad, Ganapathi, Mahrukh, Ganapathi, Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513840/
https://www.ncbi.nlm.nih.gov/pubmed/36177381
http://dx.doi.org/10.1093/narcan/zcac026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513840/
https://www.ncbi.nlm.nih.gov/pubmed/36177381
http://dx.doi.org/10.1093/narcan/zcac026

Ejemplares similares